Circulating thrombospondin-2 reflects disease severity and predicts outcome of heart failure with reduced ejection fraction.
Hanatani S, Izumiya Y, Takashio S, Kimura Y, Araki S, Rokutanda T, Tsujita K, Yamamoto E, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H.
Hanatani S, et al. Among authors: tanaka t.
Circ J. 2014;78(4):903-10. doi: 10.1253/circj.cj-13-1221. Epub 2014 Feb 6.
Circ J. 2014.
PMID: 24500070
Free article.
Clinical Trial.